Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 3

3585 - Prognosis of anaemia in disseminated testicular germ cell tumours. On behalf of the Spanish Germ Cell Cancer Group (SGCCG)


30 Sep 2019


Poster Display session 3


Tumour Site

Malignant Germ-Cell Tumours of the Adult Male


Esmeralda Garcia Torralba


Annals of Oncology (2019) 30 (suppl_5): v356-v402. 10.1093/annonc/mdz249


E. Garcia Torralba1, D. Castellano Gauna2, N. Sobrevilla3, J. Guma4, M.I. Luengo5, J. Aparicio6, A. Sanchez-Muñoz7, B. Mellado8, A. Saenz9, C. Valverde10, A. Fernández11, M. Margeli12, I. Duran13, S. Fernandez14, J. Sastre15, S. Ros16, P. Maroto17, J.L. Aguilar18, X. Garcia del Muro19, E. Gonzalez Billalabeitia20

Author affiliations

  • 1 Servicio De Hematología Y Oncología Médica, Hospital Universitario Morales Meseguer, 30008 - Murcia/ES
  • 2 Medical Oncology Department, University Hospital 12 De Octubre, 28041 - Madrid/ES
  • 3 Medical Oncology Department, Instituto Nacional de Cancerología, Mexico DF/MX
  • 4 Medical Oncology Department, Hospital Universitario Sant Joan, Reus/ES
  • 5 Medical Oncology Department, Hospital General Universitario Santa Lucía, Cartagena/ES
  • 6 Medical Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia/ES
  • 7 Medical Oncology Department, Hospital Universitario Virgen de la Victoria, Málaga/ES
  • 8 Medical Oncology Department, Hospital Clínic de Barcelona, 08036 - Barcelona/ES
  • 9 Medical Oncology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza/ES
  • 10 Medical Oncology Dept., Vall d'Hebron University Hospital, 08035 - Barcelona/ES
  • 11 Medical Oncology Department, Complejo Hospitalario Universitario de Albacete, Albacete/ES
  • 12 Urology Oncology, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona/ES
  • 13 Urology Oncology, Hospital Universitario Virgen del Rocio, Sevilla/ES
  • 14 Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo/ES
  • 15 Medical Oncology Department, Hospital Clínico San Carlos, Madrid/ES
  • 16 Oncology, Hospital Universitario Virgen de la Arrixaca, Murcia/ES
  • 17 Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona/ES
  • 18 Urological Oncology Department, Instituto Nacional de Cancerología, Mexico DF/MX
  • 19 Urology Oncology, ICO - Institut Catala d'Oncologia Hospital Duran i Reynals, 08907 - Hospitalet de Llobregat/ES
  • 20 Medical Oncology, Hospital Universitario Morales Meseguer, Murcia/ES


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 3585


Despite improvements in diagnosis and aggressive chemotherapy treatment, a proportion of young patients are still dying from germ cell cancer (GCC). We aim to identify additional prognostic factors that help to select patients that might benefit from new treatment strategies. Anaemia is prognostic in several tumours. Thus, our objective was to address the prognostic significance of anaemia in disseminated testicular GCC.


A multicentre, observational, retrospective study of patients with disseminated testicular GCC receiving first-line platinum-containing chemotherapy between 2000-2014, pooled from the Spanish Germ-Cell Cancer Group registry and another 3 tertiary hospitals. All patients with haemoglobin level available at diagnosis were selected for the analysis. We used the Cox-proportional hazard model to identify prognostic factors.


665 consecutive patients from 18 centres were included for analysis. The patient distribution according to the International Germ Cell Cancer Collaboration Group (IGCCCG) classification was: 427, 125 and 113 patients for good, intermediate and poor risk categories, respectively. Hb < 10 g/dL (anaemia) was observed in 22 (3%) patients and was associated with worse PFS (p < 0.001) and OS (p < 0.001). Anaemia was more frequently observed in the poor prognostic group (good risk: 1.4%, intermediate risk: 2.6% and poor risk: 13.1%, p < 0.001), and in the multivariate analysis we observed an interaction between anaemia and the IGCCCG classification. We then analysed the prognostic significance of anaemia in each risk group. Anaemia remained as an independent prognostic factor in the poor risk group both for PFS (HR = 2.18, 95%CI: 1.02-4.64; p = 0.04) and for OS (HR = 3.29, 95%CI: 1.42-7.65; p = 0.006). No effect was observed in the good and intermediate risk group, although statistical power was limited in these subgroups due to the low number of patients with anaemia and events.


In our series, Hb < 10 g/dL at diagnosis was an independent prognostic factor in poor risk disseminated testicular GCC. Future collaborative studies in order to validate these finding in an independent cohort are needed.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The Spanish Germ Cell Cancer Group (SGCCG).


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.